stage iiic skin melanoma
Showing 1 - 16 of 16
Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100
Terminated
- Recurrent Melanoma
- +3 more
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
- Laboratory Biomarker Analysis
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick
Active, not recruiting
- Metastatic Melanoma
- +8 more
- Aldesleukin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 20, 2021
Stage 0 Skin Melanoma, Stage I Skin Melanoma, Stage IA Skin Melanoma Trial in New Brunswick, Charlottesville (Internet-Based
Completed
- Stage 0 Skin Melanoma
- +11 more
- Internet-Based Intervention
- +2 more
-
New Brunswick, New Jersey
- +1 more
Apr 7, 2021
Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior
Completed
- Malignant Female Reproductive System Neoplasm
- +38 more
- Cognitive Behavior Therapy
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 7, 2021
Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Buffalo (procedure, drug, other)
Completed
- Recurrent Melanoma
- +9 more
- Diagnostic Microscopy
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 24, 2020
Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma Trial in Rochester (biological, drug, other)
Completed
- Stage IIA Skin Melanoma
- +6 more
- MART-1 Antigen
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 13, 2020
Stage IIIC Skin Melanoma, Stage IV Skin Melanoma Trial in Jette (nivolumab, ipilimumab)
Completed
- Stage IIIC Skin Melanoma
- Stage IV Skin Melanoma
-
Jette, Brabant, BelgiumUZ Brussel
Jan 22, 2019
Stage IIIC Skin Melanoma, Stage IV Melanoma Trial in Cleveland (lymph node, X-ACT)
Terminated
- Stage IIIC Skin Melanoma
- Stage IV Melanoma
- lymph node
- X-ACT
-
Cleveland, OhioCleveland Medical Center, University Hospitals Seidman Cancer Ce
Dec 5, 2018
Stage IA Skin Melanoma, Stage IB Skin Melanoma, Stage IIA Skin Melanoma Trial in Columbus (recombinant interferon alfa-2b,
Completed
- Stage IA Skin Melanoma
- +8 more
- recombinant interferon alfa-2b
- laboratory biomarker analysis
-
Columbus, OhioOhio State University Medical Center
Oct 31, 2018
Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial (drug, other, biological)
Withdrawn
- Stage IIIA Skin Melanoma
- +3 more
- Imatinib Mesylate
- +2 more
- (no location specified)
Apr 3, 2018
Recurrent Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma Trial in United States (biological, drug, other)
Completed
- Recurrent Melanoma
- +4 more
- Aldesleukin
- +5 more
-
Birmingham, Alabama
- +18 more
Nov 16, 2017
Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Philadelphia, Charlottesville (biological,
Completed
- Recurrent Melanoma
- +3 more
- Bevacizumab
- +3 more
-
Philadelphia, Pennsylvania
- +1 more
May 5, 2017
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)
Completed
- Anaplastic Astrocytoma
- +64 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2016
Mucosal Melanoma, Recurrent Melanoma, Stage IIIA Skin Melanoma Trial in Australia, United States (Carboplatin, Laboratory
Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Portland (gp100:209-217(210M) Peptide Vaccine, HPV
Completed
- Recurrent Melanoma
- +9 more
- gp100:209-217(210M) Peptide Vaccine
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jan 23, 2015